Category Archives: Press Releases

Home / Archive by category "Press Releases"

CareMetx, LLC Acquires VirMedica Inc., the Leader in e-Access Technology Solutions

CareMetx, LLC Acquires VirMedica Inc., the Leader in e-Access Technology Solutions

 

September 6, 2018

Contact:
Beth Dresing, edresing@caremetx.com , 301-656-1080 ext. 19

Stephen Henricks, shenricks@virmedica.com, 813-486-9484

 

BETHESDA, MD—CareMetx, LLC, a technology-enabled hub services provider for pharmaceutical and biotechnology manufacturers, today announced they have acquired VirMedica, the leader in e-access technology solutions designed to streamline patient access to life-enhancing therapies.

 

“With VirMedica’s market-leading transactions, we have an opportunity to leverage technology to transform the patient access landscape,” said Mark Hansan, CareMetx President and CEO.  “We look forward to further automating patient onboarding processes, providing efficiencies for our clients, and improving speed to therapy for all patients. We believe that these technologies can bring value to many stakeholders including manufacturers, payers, specialty pharmacies and hub providers.”

 

Gregory Morris, Chief Commercial Officer, will continue to provide leadership for VirMedica as General Manager for all market activities.  VirMedica will continue to operate out of its Boston and Shelton, CT offices.

 

“We are excited to combine VirMedica’s best of breed transactions with the robust technology and hub services assets of CareMetx and bring new unbundled solutions to the marketplace,” said Morris.

 

Beyond the complementary capabilities and technologies, Hansan cited a common theme between the two organizations that will make their union successful. Both have always made patients their priority.

 

“In the coming months, we will look at different ways to create synergies and leverage our resources, expertise and technology to benefit our customers,” said Hansan. “One thing that won’t change is our dedication to improving access for the patients we support.”

 

About CareMetx, LLC

CareMetx, LLC is a Bethesda, Maryland-based company serving pharmaceutical, biotechnology and device manufacturers with technology and specialty hub services to support the patient journey. CareMetx is committed to delivering compassionate care to patients and decision-making data and confidence-building insight to manufacturer-clients.

 

About VirMedica

VirMedica is the industry leader in providing e-access technology solutions designed to expedite patient access to life-enhancing biopharmaceutical products. VirMedica’s proprietary e-access transactions are transforming the patient access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating the processes required for patients when accessing specialty therapies.

 

Press Release

VirMedica’s Provider Portal Expands Functionality with Pharmacy Transactions

April 27, 2018 – Boston, MA – VirMedica (VMI), (www.VirMedica.com) the leader in providing e-access technology solutions designed to expedite patient access to specialty biopharmaceutical products, today announced the addition of its pharmacy “Rx” transaction suite to the Company’s provider-facing portal. The portal, called “eAccess Provider,” automates key patient onboarding activities while supporting one or more specialty therapies and is typically sponsored by a manufacturer seeking to improve patient access outcomes while lowering overall program costs.

 

eAccess Provider features the industry’s most comprehensive patient onboarding transactions, workflow modules and e-services tools designed to automate manual administrative processes required to get a patient onto a specialty therapy.  Historically, users of eAccess Provider have been able to process an automated benefit investigation for therapies covered under a patient’s medical benefit.

 

With the addition of VMI’s Rx transactions into the Portal, users can execute a medical and/or Rx benefit investigation in a single session while working within the User Interface. VMI’s Rx transactions create real-time benefits transparency by providing instant information on the patient’s pharmacy benefits and formulary status, as well as communicating patient cost share and prior authorization requirements.

 

“We’re committed to using technology to transform how providers and their patients access specialty therapies,” said Gregory R. Morris, Chief Commercial Officer for VirMedica.  “By adding our Rx transactions to eAccess Provider, we’ve made it even easier for users to understand and address complex pre-treatment steps via on-demand benefits information and automated workflow tools.”

 

The Company pioneered the development of the automated benefit investigation (MedeBV) for therapies covered under a medical benefit.  As manufacturers have sought more efficient ways to provide access to specialized therapies, VMI’s portfolio of customers has expanded.  VMI has grown to serve over 20 unique specialty brands and is on-track to assist more than 1 million patients to access therapy over the next 12 months.

 

In addition to making the Rx transactions available in the portal, VMI has also enabled the transaction within its data connectivity platform, called eAccess Exchange.  This allows the eAccess Provider portal to serve as a front-end utility, whereby transaction results are shared with other partners within the manufacturer’s patient access ecosystem.

 

About VirMedica

VirMedica is the industry leader in providing e-access technology solutions designed to expedite the patient onboarding process for biopharmaceutical products. VirMedica’s proprietary platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many pre-treatment processes required of patients and their providers.

 

Press Releases

VirMedica Announces Opening of New Corporate Office

Strong Demand for eAccess Technology Solutions Spurs Expansion in Boston
 
October 11, 2016 – Boston, MA – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that the Company has opened a new corporate office in Boston, Massachusetts. The Company also maintains an office in Shelton, Connecticut.
 
“Given the increasing demand for new technologies in the patient access market, we have decided to accelerate our hiring and subsequently are expanding our office space,” said Philip Lee, president and chief executive officer of VirMedica. “Boston, with its high concentration of biotechnology companies, top-tier academic institutions and rich talent base, offers an ideal fit with VirMedica’s mission to develop technologies to transform patient access services for specialty therapies.”
 
VirMedica’s e-access technology portfolio features the industry’s most advanced medical electronic benefit verification and workflow automation tools, a robust provider-facing portal configured around the needs of office-based injectables and e-services tools designed to automate the prior authorization process for therapies covered under a pharmacy benefit. VirMedica’s corporate office is located at 186 Lincoln Street in Boston, Massachusetts.

Press Releases

VirMedica Expands Senior Leadership Team to Support Company Growth

June 8, 2016 – Boston, MA – VirMedica, the leader in providing e-access and specialty pharmacy technology solutions designed to expedite patient access to biopharmaceutical products, today announced the appointment of three new executives to the Company’s senior leadership team. John J. Arcari has been appointed to chief financial officer (CFO) and will oversee the Company’s financial operations. Richard Deyermond joins the company as vice president of client services and will lead teams engaged in the delivery of VirMedica’s technology solutions. As the vice president of engineering, Elizabeth Ricci will focus on building out the Company’s technology suite. These executives will report directly to Philip Lee, president and chief executive officer of VirMedica, and will be located at the Company’s Boston office.

“We are pleased to welcome John, Richard and Elizabeth to the VirMedica team,” said Philip Lee, president and chief executive officer of VirMedica. “We are committed to hiring the best talent in the business to advance our technologies and deliver real value to our customers. Their collective experience, world-class leadership and deep industry expertise will be instrumental in building out the organization and executing upon our vision to transform the patient access ecosystem for biopharmaceutical products and extending RxVector, our specialty pharmacy management system. To accommodate business growth, we are also expanding our workforce significantly over the next few months.”

John Arcari’s professional tenure spans more than 30 years and includes expertise in profitability enhancement, mergers and acquisitions and financial management. Most recently, John served as an engagement partner for Tatum, a Boston-based executive services firm. Prior to that, John served as the CFO of PHT Corporation, a leading provider of electronic clinical outcome assessment systems. Previous engagements include CFO positions at CRF, Inc., Organogenesis, Inc. and Intl.com. John is a registered Certified Public Accountant in the state of Massachusetts and holds a MBA from New Mexico State University.

Richard Deyermond brings more than 30 years of leadership experience in SaaS and cloud-based software operations. Most recently, Richard served as senior vice president at Global Service Delivery, Data Intensity, a leading supplier of cloud-based and remote managed solutions for the Oracle suite. Prior to Data Intensity, Richard was vice president (VP) of product support/cloud enablement for Oracle, where he was responsible for global customer support for Oracle’s HSGBU (Health Sciences Global Business Unit). Previous to that, he was VP of customer operations at Phase Forward, which was acquired by Oracle in 2010. While at Phase Forward, Richard was responsible for all infrastructure and SaaS operations, along with global support and customer care engagement management teams supporting several leading international pharmaceutical and biotechnology companies. Richard received his B.S. in Business Administration from Fitchburg State College and his MBA from Northeastern University.

With more than 30 years in the computer software industry, Elizabeth Ricci joins VirMedica as an accomplished global software executive with a proven track record in engineering, project management and product development, with an emphasis on quality, timeliness and customer success. In her prior engagement as VP of engineering for PHT Corporation, she was responsible for all core products and was instrumental in rolling out the company’s next generation technologies. Prior positions include senior VP, products at Kadient, Inc., and senior VP, global products at Authoria, Inc. Elizabeth holds a B.A. in Mathematics from Rutgers University and a M.S. in Mathematics from Northeastern University.

About VirMedica
VirMedica is the industry leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products. The company is also a leader in providing specialty pharmacy management solutions. VirMedica’s proprietary platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many pre-treatment processes required of patients and their providers. For more information about VirMedica and its portfolio of proprietary e-access technology solutions, please visit: http://virmedica.com/.

Press Releases

VirMedica Board of Directors Appoints Industry Veteran Philip Lee as President and Chief Executive Officer

 

April 11, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that its Board of Directors has appointed Philip Lee as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately.

 

“As we enter an important growth stage for VirMedica, the Board of Directors welcomes Phil’s impressive leadership and industry experience along with his passion and proven success driving corporate performance in the healthcare arena,” said John H. Johnson, chairman of VirMedica. “In his role as president and CEO, Phil will be responsible for advancing VirMedica’s proprietary e-access technology, extending our track record of innovation and delivering upon our core mission to expedite the patient journey to potentially life-enhancing biopharmaceutical products,” Johnson added.

 

Mr. Lee is a seasoned industry leader with more than 35 years of executive management and leadership experience across a wide range of enterprise solutions for Fortune 1000 clients. He has spent the past two decades driving innovation and accelerating drug development for the life sciences industry. Mr. Lee most recently served as president and chief executive officer of PHT Corporation, a leading provider of electronic clinical outcome assessments solutions for the biopharmaceutical industry, which was acquired in 2015 by ERT, a leading provider of patient data collection services. Mr. Lee’s prior executive management positions included serving as president of eXcelon Corporation and as president and CEO of Clinsoft. Earlier in his career, Mr. Lee held roles of increasing responsibility at Bolt, Beranek & Neumann, Interleaf, Inc., Oracle Corporation and Digital Equipment Corporation. Mr. Lee was named Ernst & Young ‘Entrepreneur of the Year’ finalist in 2012 and 2013, one of PharmaVoice’s ‘100 Most Inspirational People in Life Sciences’ and as a ‘Tech Luminary of the Year’ by Mass High Tech and The Boston Business Journal in 2012. Mr. Lee earned a B.S. in Operations Research and Industrial Engineering and a Master of Engineering degree from Cornell University.

 

“The industry faces unprecedented opportunities and challenges posed by the increasingly complex patient access landscape. There is tremendous demand for technology solutions that can simplify the often-complicated path that providers and their patients must navigate prior to accessing treatment. I look forward to working closely with John, the Board of Directors and management team to further transform the patient access ecosystem, grow VirMedica’s business across all segments of the Company’s enterprise and to better serve our customers and ultimately patients,” said Philip Lee, president and chief executive officer of VirMedica.

 

About VirMedica

VirMedica is the industry leader in providing e-access technology solutions designed to expedite patient access to potentially life-enhancing biopharmaceutical products. VirMedica’s proprietary e-access platforms are transforming the market access landscape for biopharmaceutical products through simplifying, automating and ultimately accelerating many processes for patients and providers within the market access ecosystem.

 

Contacts:

 

Corporate & Media Relations

 

Stephen J. Henricks

VP, Marketing

Shenricks@virmedica.com

+1 203-840-6817

 

Lindsay M. Rocco

Elixir Health Public Relations

lrocco@elixirhealthpr.com

+1 862-596-1304

 

 

Press Releases

VirMedica to Present at CBI’s 6th HUB and SPP Model Optimization Conference

February 22, 2016 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions designed to expedite patient access to biopharmaceutical products, today announced that the Company will be participating in CBI’s 6th HUB and SPP Model Optimization Conference.
 

CBI’s Hub Model Conference Series brings together esteemed leaders in patient access, brand management, reimbursement and specialty distribution across the healthcare industry and focuses on breakthrough strategies and service model design and enhancement to improve access and outcomes.
 

read more…

Press Release

 John H. Johnson appointed as Executive Chairman of the Board

November 9, 2015 – Philadelphia, Pa. – VirMedica, the leader in providing e-access technology solutions, announced the appointment of John H. Johnson as executive chairman.

John H. Johnson is a recognized leader in the biopharmaceutical industry with more than 30 years of experience at leading global organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone and Pfizer, Inc. He currently serves as chairman of Strongbridge Biopharma plc, and as a member of the board of directors of Cempra Pharmaceuticals, Inc., Histogenics Corporation, Portola Pharmaceuticals, Inc., and Sucampo Pharmaceuticals, Inc. He previously served as a member of the board of directors of Pharmaceutical Research and Manufacturers of America (PhRMA), the Health Section Governing Board of Biotechnology Industry Organizations (BIO), and BioNJ.
read more…

Press Release

VirMedica Makes Capital Investment in D2 Pharma Consulting

February 19, 2015 – Philadelphia, PA – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that it has made a significant capital investment in D2 Pharma Consulting, LLC (“D2”). D2 is an independent consulting firm offering a broad range of commercialization services for manufacturers and service providers in the life sciences industry.

read more…

Press Release

VirMedica Continues to Expand Capabilities through Acquiring Assets of TransEngen, Inc.

February 19, 2015 – Philadelphia, PA. – VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that VirMedica, Inc. (“VirMedica”) has acquired the assets of TransEngen, Inc.

read more…